Christine Pierre

1.5k total citations · 1 hit paper
12 papers, 1.0k citations indexed

About

Christine Pierre is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pharmacology. According to data from OpenAlex, Christine Pierre has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Christine Pierre's work include Ethics in Clinical Research (4 papers), Health and Medical Research Impacts (4 papers) and Meta-analysis and systematic reviews (2 papers). Christine Pierre is often cited by papers focused on Ethics in Clinical Research (4 papers), Health and Medical Research Impacts (4 papers) and Meta-analysis and systematic reviews (2 papers). Christine Pierre collaborates with scholars based in United States, France and Canada. Christine Pierre's co-authors include M. Elmer, Gary A. Puckrein, Brenda D. Jamerson, Ola Akinboboye, Adam B. Polis, Laurence O. Watkins, Ileana L. Piña, Jeanne M. Regnante, Luther T. Clark and Claire Poyart and has published in prestigious journals such as The Lancet Oncology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Christine Pierre

12 papers receiving 976 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increasing Diversity in Clinical Trials: Overcoming Critical Barriers

2018 465 citations Luther T. Clark, Laurence O. Watkins et al. Current Problems in Cardiology profile →

Peers

Christine Pierre

PHEOH

MB

PRM

GHP

RNMI

Vinay Gupta United States

Denese C. Marks Australia

Kaneez Fatima Pakistan

Caroline Fenton New Zealand

Masumi Ueda United States

Gilad S. Gordon United States

Kate Traynor United States

Jane E. Henney United States

Jorge Ferreira Portugal

Christopher McCoy United States

Vinay Gupta United States

Christine Pierre

147 ×0.5

PHEOH

271 ×1.3

MB

64 ×0.4

PRM

99 ×0.7

GHP

127 ×0.9

RNMI

Citations per year, relative to Christine Pierre Christine Pierre (= 1×) peers Vinay Gupta

Countries citing papers authored by Christine Pierre

Since Specialization

Citations

This map shows the geographic impact of Christine Pierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Pierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Pierre more than expected).

Fields of papers citing papers by Christine Pierre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Pierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Pierre. The network helps show where Christine Pierre may publish in the future.

Co-authorship network of co-authors of Christine Pierre

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Pierre. A scholar is included among the top collaborators of Christine Pierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Pierre. Christine Pierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Fordyce, Christopher B., Matthew T. Roe, Christine Pierre, et al.. (2019). Trends in clinical trial investigator workforce and turnover: An analysis of the U.S. FDA 1572 BMIS database. Contemporary Clinical Trials Communications. 15. 100380–100380. 7 indexed citations

2.

Clark, Luther T., Laurence O. Watkins, Ileana L. Piña, et al.. (2018). Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Current Problems in Cardiology. 44(5). 148–172. 465 indexed citations breakdown →

3.

Hanf, Rémy, Christine Pierre, John Brozek, et al.. (2018). Validation of NIS4 algorithm for detection of NASH at risk of cirrhosis in 467 NAFLD patients prospectively screened for inclusion in the RESOLVE-IT trial. Journal of Hepatology. 68. S115–S116. 1 indexed citations

4.

Corneli, Amy, et al.. (2017). One and done: Reasons principal investigators conduct only one FDA-regulated drug trial. Contemporary Clinical Trials Communications. 6. 31–38. 15 indexed citations

5.

Pierre, Christine, et al.. (2016). Inter Prediction Complexity Reduction for HEVC based on Residuals Characteristics. International Journal of Advanced Computer Science and Applications. 7(10). 2 indexed citations

6.

Abbott, Diana, et al.. (2013). Cycle Time Metrics for Multisite Clinical Trials in the United States. Therapeutic Innovation & Regulatory Science. 47(2). 152–160. 14 indexed citations

7.

Divgi, Chaitanya, Neeta Pandit‐Taskar, Achim A. Jungbluth, et al.. (2007). Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. The Lancet Oncology. 8(4). 304–310. 250 indexed citations

8.

Friedman, Joëlle Y., Jeremy Sugarman, Jatinder Kaur Dhillon, et al.. (2007). Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants. Clinical Trials. 4(3). 272–278. 6 indexed citations

9.

Cola, Philip A., et al.. (2005). Responsible research : a guide for coordinators. DigitalGeorgetown (Georgetown University Library). 10 indexed citations

10.

Pierre, Christine, et al.. (2000). 1,3-Disubstituted-2-carboxy quinolones: highly potent and selective endothelin A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(13). 1487–1490. 7 indexed citations

11.

Musicki, Branislav, Patrick Laurin, Didier Ferroud, et al.. (2000). Improved antibacterial activities of coumarin antibiotics bearing 5′,5′-dialkylnoviose: biological activity of RU79115. Bioorganic & Medicinal Chemistry Letters. 10(15). 1695–1699. 111 indexed citations

12.

Poyart, Claire, Christine Pierre, Gilles Quesne, et al.. (1997). Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrobial Agents and Chemotherapy. 41(1). 24–29. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact